Horizon Therapeutics Plc (HZNP)


Stock Price Forecast

Oct. 5, 2023


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Horizon Therapeutics Plc chart...

About the Company

at horizon therapeutics, we believe science and compassion must work together to transform lives. we are driven to deliver innovative medicines to those living with rare, autoimmune and severe inflammatory diseases because we uniquely understand the patient journey. for us, success is measured by the numbers that matter most – the number of lives we touch, the number we change and those we work to help save.

CEO

Timothy P Walbert

Exchange

NASDAQ

Website

horizontherapeutics.com

$280M

Total Revenue

1K

Employees

$27B

Market Capitalization

63.56

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $HZNP News

20 Fastest Growing Health Tech Companies in the World

18h ago, source:

In this article, we will be taking a look at the 20 fastest growing health tech companies in the world. If you do not want to ...

Rx Rundown: Vertex Pharmaceuticals, Bristol Myers Squibb, Novartis and more

13d ago, source: MM&M

Vertex Pharmaceuticals announced its biggest M&A play yet, acquiring Alpine Immune Sciences for $4.9 billion. MM+M is proud ...

Life Sciences Industry Continues To Thrive

15d ago, source: Business Facilities

Locations are eager to attract companies in the life sciences industry by meeting their needs for educated workers and access ...

Novel Drug Made of Gold Nanocrystals Appears Safe in Multiple Sclerosis

3d ago, source: MedPage Today on MSN

DENVER -- An oral suspension of clean-surfaced gold nanocrystals known as CNM-Au8 was safe and well-tolerated in patients ...

Jim Cramer’s 10 Favorite Healthcare Stock Picks in 2024

12d ago, source:

In this article, we will take a detailed look at Jim Cramer’s 10 Favorite Healthcare Stock Picks in 2024. For a quick ...

The world may be entering a post-equity era, and the UK is the canary in the coalmine

on MSN ago, source:

It seems we’ve all been scanning the wrong horizon on the lookout for danger. In August 1979, the headline on Businessweek’s ...

Inflation Reduction Act: A Bullish Catalyst For Viatris Inc.

1d ago, source:

Discover the impact of the Inflation Reduction Act on generic drugs, benefiting certain stocks in the pharmaceutical sector.

BHP makes $60 billion bid for Anglo American

12h ago, source:

Shares in BHP (ASX:BHP) will come under pressure on the ASX on Friday after it confirmed it had made an unsolicited all-paper ...

Meghan Markle Sends Her Famous Friends the 1st American Riviera Orchard Products Ahead of Launch

9d ago, source: US Weekly on MSN

Meghan announced her new business venture on March 14 when launching the lifestyle brand’s Instagram account following a five ...

Top Analyst Reports for Novartis, American Express & ConocoPhillips

Opinion ago, source: Zacks.com on MSN

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Novartis AG (NVS), American Express ...

High Lipoprotein(a) Levels' Hit on Heart Health Doesn't Discriminate

10d ago, source: MedPage Today on MSN

All sex, race, and risk category groups appeared to be affected by the heart disease risk posed by elevated lipoprotein (a), ...

Tissue Engineering and Regeneration Market [2028]: Navigating Opportunities and Challenges

2d ago, source:

USD 14.57 billion in 2022 and is poised for substantial growth, projecting a Compound Annual Growth Rate (CAGR) of 8.35% ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...